Exploring Receptor Binding Affinities and Hepatic Cell Association of N -Acetyl- d -Galactosamine-Modified β-Cyclodextrin-Based Polyrotaxanes for Liver-Targeted Therapies
Biomacromolecules · 2023
DOI: 10.1021/acs.biomac.3c00194 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomacromolecules, 2023. Verfasst von Moe Ohashi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Organic Biomaterials, Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University (TMDU), 2-3-10 Kanda-Surugadai,…. Hauptthemen laut MEDLINE: Rotaxanes, beta-Cyclodextrins. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 72 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Organic Biomaterials, Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University (TMDU), 2-3-10 Kanda-Surugadai, Chiyoda, Tokyo 101-0062, Japan.
ORCID-Profile: Atsushi Tamura, Nobuhiko Yui
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Ohashi, M., Tamura, A., & Yui, N. (2023). Exploring Receptor Binding Affinities and Hepatic Cell Association of N -Acetyl- d -Galactosamine-Modified β-Cyclodextrin-Based Polyrotaxanes for Liver-Targeted Therapies. Biomacromolecules. https://doi.org/10.1021/acs.biomac.3c00194
Vancouver
Ohashi M, Tamura A, Yui N. Exploring Receptor Binding Affinities and Hepatic Cell Association of N -Acetyl- d -Galactosamine-Modified β-Cyclodextrin-Based Polyrotaxanes for Liver-Targeted Therapies. Biomacromolecules. 2023. doi:10.1021/acs.biomac.3c00194
BibTeX
@article{Ohashi2023,
author = {Ohashi, Moe and Tamura, Atsushi and Yui, Nobuhiko},
title = {Exploring Receptor Binding Affinities and Hepatic Cell Association of N -Acetyl- d -Galactosamine-Modified β-Cyclodextrin-Based Polyrotaxanes for Liver-Targeted Therapies},
journal = {Biomacromolecules},
year = {2023},
doi = {10.1021/acs.biomac.3c00194}
}
EUVIMED